Electric field therapy for brain tumors: a new hope?
NCT ID NCT05310448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests the safety of a wearable device called Optune that creates low-intensity electric fields to disrupt cancer cell division in brainstem gliomas. Ten adults with this rare brain tumor will wear the device to see if it can slow tumor growth without serious side effects. The goal is to control the disease, not cure it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAINSTEM GLIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Proton Therapy Center
NOT_YET_RECRUITINGAtlanta, Georgia, 30308, United States
-
Emory Saint Joseph's Hospital
NOT_YET_RECRUITINGAtlanta, Georgia, 30342, United States
-
Emory University/Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can adding lenvatinib to standard care outsmart a tough brain cancer?
- Can a sharper beam of radiation shield the mind during brain tumor treatment?
- Could a parasite drug fight childhood brain tumors?
- Can a tiny implant trap brain tumor cells and make radiation work better?
- Can a targeted pill slow brain tumor growth after surgery?